Market closedADR

Smith & Nephew/$SNN

14:30
16:10
17:45
19:25
21:00
1D1W1MYTD1Y5YMAX

About Smith & Nephew

Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound care solutions. Roughly 41% of the UK-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 29% of revenue is from the advanced wound therapy segment. Over half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.

Ticker

$SNN

Trading on

NYSE

Industry

Health Care Equipment & Supplies

Employees

18,000

Smith & Nephew Metrics

BasicAdvanced
$11B
Market cap
73.92
P/E ratio
$0.35
EPS
0.58
Beta
$0.73
Dividend rate
2.12%
Dividend yield
$11B
0.58
$31.53
$23.65
933K
$0.73
2.509
1.107
62.92
70.221
107.54%
5.25%
4.51%
5.84%
73.918
3.984
1.66
8.76
74.673
2.81%
2.12%
5.48%
39.77%
3.26%
-17.85%

What the Analysts think about Smith & Nephew

Analyst Ratings

Analyst ratings (Buy, Hold, Sell) for Smith & Nephew stock.

Smith & Nephew Financial Performance

Income Statement

Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%

Smith & Nephew Earnings Performance

Earnings per share (EPS)

Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.

Buy $SNN

$

Sign up or log in to buy
Capital at risk
Market closedADR

Upcoming events

No upcoming events

FAQs

What’s the current market cap for Smith & Nephew stock?

Smith & Nephew (SNN) has a market cap of $11B as of December 11, 2024.

What is the P/E ratio for Smith & Nephew stock?

The price to earnings (P/E) ratio for Smith & Nephew (SNN) stock is 73.92 as of December 11, 2024.

Does Smith & Nephew stock pay dividends?

Yes, the Smith & Nephew (SNN) stock pays dividends to shareholders. As of December 11, 2024, the dividend rate is $0.725 and the yield is 2.12%. Smith & Nephew has a payout ratio of 107.54% on a trailing twelve-month basis.

When is the next Smith & Nephew dividend payment date?

The next Smith & Nephew (SNN) dividend payment date is unconfirmed.

What is the beta indicator for Smith & Nephew?

Smith & Nephew (SNN) has a beta rating of 0.58. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.